MPLT
NASDAQ · Biotechnology
Maplight Therapeutics Inc
$27.40
-1.80 (-6.16%)
Open$29.22
Previous Close$29.20
Day High$29.95
Day Low$27.00
52W High$33.28
52W Low$12.24
Volume—
Avg Volume297.2K
Market Cap1.24B
P/E Ratio—
EPS$-18.56
SectorBiotechnology
Analyst Ratings
Strong Buy
11 analysts
Price Target
+130.6% upside
Current
$27.40
$27.40
Target
$63.19
$63.19
$44.21
$63.19 avg
$83.67
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 110.57M | 109.60M | 110.00M |
| Net Income | -5,057,192 | -4,807,023 | -6,303,306 |
| Profit Margin | -4.6% | -4.4% | -5.7% |
| EBITDA | -7,551,548 | -8,325,034 | -7,754,101 |
| Free Cash Flow | -7,533,825 | -4,832,804 | -6,604,673 |
| Rev Growth | +23.3% | +7.4% | -2.1% |
| Debt/Equity | 0.30 | 0.38 | 0.35 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $201.55 | -0.57% | 88.1 | 372.29B |
| AMGN | Amgen Inc | $331.70 | +0.79% | 22.7 | 176.88B |
| GILD | Gilead Sciences Inc | $131.33 | -2.04% | 19.3 | 163.92B |
| VRTX | Vertex Pharmaceuticals Inc | $429.82 | +1.13% | 27.7 | 109.50B |
| REGN | Regeneron Pharmaceuticals | $714.89 | +0.82% | 16.5 | 74.30B |
| ALNY | Alnylam Pharmaceuticals Inc | $295.05 | -0.29% | 130.4 | 40.90B |